Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy
Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy
Updated:
May 27, 2021 11:36 IST
Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the “single dose infusion-based treatment.”
Share Article
AAA
Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the “single dose infusion-based treatment.” An 84-year-old COVID-positive man who was given monoclonal antibody therapy in Gurgaon, which is said to reduce the chance of hospitalisation by 70% in patients with mild to moderate symptoms, is back to his home, hospital authorities said on Wednesday. Mohabbat Singh was administered a cocktail of Casirivimab and Imdevimab at the Medanta Hospital as part of the “single dose infusion-based treatment” on Tuesday and then kept under observation.